CA2616698A1 - Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome - Google Patents

Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome Download PDF

Info

Publication number
CA2616698A1
CA2616698A1 CA002616698A CA2616698A CA2616698A1 CA 2616698 A1 CA2616698 A1 CA 2616698A1 CA 002616698 A CA002616698 A CA 002616698A CA 2616698 A CA2616698 A CA 2616698A CA 2616698 A1 CA2616698 A1 CA 2616698A1
Authority
CA
Canada
Prior art keywords
molecular cloning
virus genome
dna virus
modified eukaryotic
direct molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002616698A
Other languages
French (fr)
Other versions
CA2616698C (en
Inventor
Friedrich Dorner
Friedrich Scheiflinger
Falko Gunter Falkner
Michael Pfleiderer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Original Assignee
Baxter Healthcare S.A.
Friedrich Dorner
Friedrich Scheiflinger
Falko Gunter Falkner
Michael Pfleiderer
Immuno Aktiengesellschaft
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/750,080 external-priority patent/US5445953A/en
Application filed by Baxter Healthcare S.A., Friedrich Dorner, Friedrich Scheiflinger, Falko Gunter Falkner, Michael Pfleiderer, Immuno Aktiengesellschaft, Baxter Aktiengesellschaft filed Critical Baxter Healthcare S.A.
Priority claimed from CA002558864A external-priority patent/CA2558864C/en
Publication of CA2616698A1 publication Critical patent/CA2616698A1/en
Application granted granted Critical
Publication of CA2616698C publication Critical patent/CA2616698C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides a plasmid for producing a modified chordopoxvirus, wherein the plasmid comprises a first master cloning site that includes unique sites of a second master cloning site of the vaccinia virus vector designated vdTK, selected from the following group of plasmids shown in Figure 4.3: pA0 comprising the sequence of SEQ. ID. NO. 6, pA1 comprising the sequence of SEQ. ID. NO.
7, and pA2 comprising the sequence of SEQ. ID. NO. 8.
CA002616698A 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome Expired - Fee Related CA2616698C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/750,080 1991-08-26
US07/750,080 US5445953A (en) 1991-08-26 1991-08-26 Direct molecular cloning of a modified poxvirus genome
US91473892A 1992-07-20 1992-07-20
US07/914,738 1992-07-20
CA002558864A CA2558864C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002558864A Division CA2558864C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Publications (2)

Publication Number Publication Date
CA2616698A1 true CA2616698A1 (en) 1993-02-27
CA2616698C CA2616698C (en) 2009-03-17

Family

ID=39103181

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002616717A Abandoned CA2616717A1 (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA2617830A Expired - Fee Related CA2617830C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA002616698A Expired - Fee Related CA2616698C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CA002616717A Abandoned CA2616717A1 (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA2617830A Expired - Fee Related CA2617830C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Country Status (1)

Country Link
CA (3) CA2616717A1 (en)

Also Published As

Publication number Publication date
CA2617830A1 (en) 1993-02-27
CA2616717A1 (en) 1993-02-27
CA2617830C (en) 2010-04-06
CA2616698C (en) 2009-03-17

Similar Documents

Publication Publication Date Title
HK1016218A1 (en) Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv.
AU9338598A (en) Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences
AU8067698A (en) Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
AU692163B2 (en) Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells
CA2142746A1 (en) Rev-independent hiv expression and replication
CA2248543A1 (en) Directed switch-mediated dna recombination
BG101384A (en) New pesticide proteins and strains
CA2153254A1 (en) Cloning of enterokinase and method of use
AU1884392A (en) Peptide nucleic acids
AU3636189A (en) Hiv-2 virus variants
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
AU6704496A (en) Helper viruses for the preparation of recombinant viral vectors
AU5639494A (en) Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same
AU6839898A (en) Vaccine composition for preventing or treating c hepatitis
EP1262554A3 (en) Defective packaging non-oncoviral vectors based on mpmv and hiv
AU657488B2 (en) New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process
WO2002016617A3 (en) Myrosinase from brevicoryne brassicae
CA2616698A1 (en) Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
EP0604850A3 (en) Novel olefin polymerizing catalyst, method for preparing it and use for the polymerization of olefins.
AU3059697A (en) Molecular genetic construction of vaccine strains of pasteurellaceae
CA2066998A1 (en) Recombinant varicella-zoster virus and process for constructing same
AU7470096A (en) Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences
CA2332623A1 (en) Recombinant herpes viruses for preparing recombinant adeno-associated viruses
CA2217633A1 (en) Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
AU1099697A (en) Novel xylanases, genes encoding them, and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed